ACELINK THERAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 04 Jun 2025)
What this means for you
Not registered yet, but its 18 Feb 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97273549
- Mark type
- Stylized text
- Filed
- 18 Feb 2022
- Published for opposition
- 18 Apr 2023
- Attorney of record
- Yi Zhang
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical products for the prevention and treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for treating glycolipid storage diseases, diseases associated with glycolipid accumulation
Owner
- ACELINK THERAPEUTICS, INC., Newark, CA, US
- ACELINK THERAPEUTICS, INC., Newark, CA, US
Prosecution history
- 10 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Jun 2025 — SOU EXTENSION 4 GRANTED
- 03 Jun 2025 — SOU EXTENSION 4 FILED
- 03 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Dec 2024 — SOU EXTENSION 3 GRANTED
- 13 Dec 2024 — SOU EXTENSION 3 FILED
- 13 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 12 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jun 2024 — SOU EXTENSION 2 GRANTED
- 13 Jun 2024 — SOU EXTENSION 2 FILED
- 12 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 15 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Dec 2023 — SOU EXTENSION 1 GRANTED